📰 Breakthrough Therapy News
Page 2 - Breakthrough Therapy News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Breakthrough Therapy. Real-time updates on events, politics, business and more.
May 29, 2024
Hallucinogens in mental health are increasingly being investigated in the drug pipeline, especially for depressive disorders and PTSD.
May 28, 2024
28.05.2024 - NEW HAVEN, Conn., May 28, 2024 (GLOBE NEWSWIRE) - BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced ... Seite 1
May 28, 2024
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders,
May 28, 2024
Press release - Getnews - First Choice Chiropractic: Leading Excellence in Holistic Wellness - published on openPR.com
May 28, 2024
Brensocatib is an oral, reversible inhibitor of dipeptidyl peptidase 1.
May 23, 2024
89bio, Inc. announced that data from the 48-week extension phase of the Phase 2b ENLIVEN trial evaluating pegozafermin in patients with metabolic dysfunction-associated steatohepatitis with fibrosis...
May 23, 2024
DREAMM-8 results for Blenrep in multiple myeloma featured in a late-breaking presentation and ASCOs Press Programme Updated results from a supported...
May 22, 2024
The designation was supported by data from the double-blind, placebo-controlled phase 2b AHFIRM trial.
May 21, 2024
The designation is based on Phase III INAVO120 results, showing the inavolisib-based regimen more than doubled progression-free survival compared with palbociclib and fulvestrant alone in the...
May 21, 2024
The designation is based on Phase III INAVO120 results, showing the inavolisib-based regimen more than doubled progression-free survival compared with palbociclib and fulvestrant alone in the first-line